跳至主要内容
临床试验/NCT03674385
NCT03674385已完成2 期

Evaluation of the Clinical Outcome of Vitamin E as Adjuvant Therapy in Patients With Clomiphene Citrate Resistant Polycystic Ovary Syndrome

Ain Shams University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年7月19日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
60
试验地点
1
主要终点
ovulation rate

研究概览

简要总结

This study evaluate the addition of Vit E to clomiphene citrate in the treatment of poly cystic ovary.Half the patients will receive both Vit E and clomiphene citrate the other half will receive clomiphene citrate only.

详细描述

Clomiphene and vit E each used in treatment of pco but they do so by different mechanisms.

Clomifene is in the selective estrogen receptor modulator (SERM) family of medication. It works by causing the release of gonadotropin-releasing hormone by the hypothalamus, and subsequently gonadotropin from the anterior pituitary.

Vit E is used in treatment of pco due its anti-oxidant effect.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 39 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients will be diagnosed as having PCOS according to the Rotterdam criteria for diagnosis of PCOS
  • Age between 18 and 39 years.
  • Period of infertility >1 years.
  • No treatment taken during the last 2 months.
  • Patients who have previously received clomiphene citrate (CC) and being diagnosed as having CC resistance

排除标准

  • History of pelvic surgery or infertility factor other than anovulation
  • Endocrine disorders in the form of hypothyroidism or hyperthyroidism, hyperprolactinemia, and Cushing syndrome, as detected by history, examination, or investigations.
  • Known cases of endometriosis (approved histologically), uterine anomaly or hydrosalpinx, retinitis pigmentosa and vitamin K deficiency.
  • Consumption of vitamin and antioxidant supplementations in the last three-months before the trial start date.
  • Male factor infertility (sperm count < 5 million per milliliter, normal morphology <4%).
  • Elevated serum prolactin, T.S.H and F.S.H.
  • Patients diagnosed with diabetes mellitus

研究组 & 干预措施

vitamin E group

Experimental

30 patient

干预措施: Clomiphene Citrate (Drug)

vitamin E group

Experimental

30 patient

干预措施: vitamin E (Dietary Supplement)

vitamin E group

Experimental

30 patient

干预措施: Metformin (Drug)

control group

Active Comparator

clomiphene

干预措施: Metformin (Drug)

control group

Active Comparator

clomiphene

干预措施: Clomiphene Citrate (Drug)

结局指标

主要结局

ovulation rate

时间窗: 3 months

Follicles measure more than 18 mm will be considered mature follicles.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Abbas Morsy Morsy

pharmacist

Ain Shams University

研究点 (1)

Loading locations...

相似试验